Castleview Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
4,044
+1,130
+39% +$263K 0.45% 49
2026
Q1
$712K Buy
2,914
+203
+7% +$47.3K 0.37% 64
2025
Q4
$561K Buy
2,711
+344
+15% +$68K 0.28% 83
2025
Q3
$439K Buy
2,367
+175
+8% +$30K 0.24% 88
2025
Q2
$335K Buy
2,192
+7
+0.3% +$1.08K 0.22% 118
2025
Q1
$362K Sell
2,185
-504
-19% -$78.9K 0.25% 106
2024
Q4
$387K Buy
2,689
+164
+6% +$25.4K 0.21% 116
2024
Q3
$409K Sell
2,525
-53
-2% -$8.44K 0.24% 104
2024
Q2
$377K Buy
2,578
+102
+4% +$15.2K 0.21% 110
2024
Q1
$392K Buy
2,476
+324
+15% +$51.6K 0.22% 109
2023
Q4
$337K Buy
2,152
+590
+38% +$90.5K 0.24% 101
2023
Q3
$243K Sell
1,562
-71
-4% -$11.7K 0.22% 99
2023
Q2
$270K Sell
1,633
-589
-27% -$95.1K 0.24% 90
2023
Q1
$344K Buy
2,222
+10
+0.5% +$1.61K 0.31% 81
2022
Q4
$391K Buy
2,212
+126
+6% +$21.8K 0.38% 64
2022
Q3
$341K Buy
2,086
+1,988
+2,029% +$336K 0.33% 73
2022
Q2
$17.1K Sell
98
-4,009
-98% -$714K 0.01% 401
2022
Q1
$727K Sell
4,107
-658,354
-99% -$112M 0.45% 40
2021
Q4
$3.87K Buy
+662,461
New +$108M 0.03% 193
2021
Q2
$692K Buy
+4,199
New +$695K 0.3% 65
2018
Q1
$729K Buy
+5,690
New +$769K 0.6% 42

Other funds holding JNJ

Castleview Partners's JNJ Position: Q2 2026 in Review

Castleview Partners increased its Johnson & Johnson (JNJ) stake by 39% in Q2 2026, buying an estimated $263K and bringing the position to 4,044 shares worth $1.03M. The position accounts for 0.45% of the portfolio, ranked #49.

Castleview Partners first reported a position in JNJ in Q1 2018 and has held it in 21 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Castleview Partners held 4,044 shares of Johnson & Johnson worth $1.03M as of Q2 2026.
  • Castleview Partners bought 1,130 Johnson & Johnson shares in Q2 2026, an estimated $263K.
  • Johnson & Johnson made up 0.45% of Castleview Partners's portfolio in Q2 2026, its #49 holding.
  • Castleview Partners first reported a position in Johnson & Johnson in Q1 2018 and has held it in 21 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.